Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation
- PMID: 227991
- DOI: 10.1099/0022-1317-44-1-205
Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation
Abstract
The role of antiviral antibody in controlling the acute and latent phases of herpes simplex virus (HSV) infection in sensory ganglia of mice was studied in vitro and in vivo. Organ cultures of ganglia inoculated in vitro with HSV produced infectious virus for at least 3 weeks. In the presence of antiviral antibody, the titre of virus was markedly reduced, but the infection was not eliminated. Similarly, passive administration of antibody to HSV-infected immunodeficient (nude) mice reduced the virus titre but did not eliminate the acute phase of the ganglionic infection. Suppression of the cell-mediated immune response in latently infected immunocompetent mice by treatment with cyclophosphamide and/or X-irradiation resulted in reactivation of HSV in up to 70% of the animals. Reactivation was demonstrated by recovering infectious virus in cell-free homogenates of ganglia and eye globes and by finding virus antigens in ganglia by immunofluorescent staining. Reactivation occurred both in vitro and in vivo in the presence of high concentrations of neutralizing antibody. It is concluded that antibody alone is not sufficient to eliminate the acute phase of the ganglionic infection and that cytotoxic agents known to suppress the host's cellular immune response can reactivate virus in the presence of neutralizing antibody.
Similar articles
-
Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.Jpn J Exp Med. 1978 Oct;48(5):427-35. Jpn J Exp Med. 1978. PMID: 219274
-
Latency of herpes simplex virus in absence of neutralizing antibody: model for reactivation.Science. 1980 Nov 28;210(4473):1026-8. doi: 10.1126/science.6254149. Science. 1980. PMID: 6254149
-
Quantification of herpes simplex virus infection in cervical ganglia of mice.J Gen Virol. 1989 Jul;70 ( Pt 7):1779-88. doi: 10.1099/0022-1317-70-7-1779. J Gen Virol. 1989. PMID: 2472466
-
The continuing problem of herpes simplex virus persistence.Acta Virol. 1983 Sep;27(5):442-50. Acta Virol. 1983. PMID: 6139950 Review.
-
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.Am J Med. 1982 Jul 20;73(1A):138-42. doi: 10.1016/0002-9343(82)90079-1. Am J Med. 1982. PMID: 6285703 Review.
Cited by
-
Herpes simplex virus, type 1 invasion of the rabbit and mouse nervous systems revealed by in situ hybridization.Acta Neuropathol. 1987;74(2):124-32. doi: 10.1007/BF00692842. Acta Neuropathol. 1987. PMID: 2823520
-
Initial herpes simplex virus type 1 infection prevents ganglionic superinfection by other strains.Infect Immun. 1982 Mar;35(3):1125-32. doi: 10.1128/iai.35.3.1125-1132.1982. Infect Immun. 1982. PMID: 6279513 Free PMC article.
-
Establishment of an Alzheimer's disease model with latent herpesvirus infection using PS2 and Tg2576 double transgenic mice.Exp Anim. 2018 May 10;67(2):185-192. doi: 10.1538/expanim.17-0066. Epub 2017 Nov 29. Exp Anim. 2018. PMID: 29187699 Free PMC article.
-
Antibody-mediated destruction of virus-infected cells.Adv Immunol. 1980;29:209-60. doi: 10.1016/s0065-2776(08)60045-0. Adv Immunol. 1980. PMID: 6251708 Free PMC article. Review.
-
Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide.Arch Virol. 1988;99(1-2):57-65. doi: 10.1007/BF01311023. Arch Virol. 1988. PMID: 2833203
MeSH terms
Substances
LinkOut - more resources
Full Text Sources